Rheumatoid Arthritis Clinical Trials in Chicago

Showing 1281-1300 of 1,857 trials

rTMS: A Treatment to Restore Function After Severe TBI

NCT02366754

The purpose of this study is to address the need for targeted treatments that induce functional and structural changes in the brain, ultimately improving neurobehavioral functioning, the investigators propose examining the therapeutic effectiveness of repetitive Transcranial Magnetic Stimulation (rTMS). The objective is to improve functional recovery for persons remaining in vegetative (VS) and minimally conscious (MCS) states 3 to 24 months after severe TBI. The approach is to determine the neurobehavioral effect of rTMS, the relationship between neurobehavioral changes and net neural effects, and to identify and define the neural mechanisms related to neurobehavioral improvements by providing 30 active or placebo rTMS sessions.

Traumatic Brain Injury

Edward Hines Jr. VA Hospital58 participantsStarted Feb 2016

Chicago, Illinois, United States • Hines, Illinois, United States

COMPLETEDPhase 32.2 miles

An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine

NCT02873221

This study will evaluate the long-term safety and tolerability of intermittent treatment with ubrogepant for the acute treatment of migraine over 1 year.

Migraine, With or Without Aura

Allergan1,254 participantsStarted Sep 2016

Birmingham, Alabama, United States • Chandler, Arizona, United States • Mesa, Arizona, United States +174 more locations

rTMS: A Treatment to Restore Function After Severe TBI

An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine

Rheumatoid Arthritis Trials in Other Cities

Study of Insulin-like Growth Factor (IGF)-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R

A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation

Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection

Autologous Transplant Using Dose-Escalated Total Body Irradiation & Cyclophosphamide & Palifermin for NHL

Use of Cyclobenzaprine After Vaginal Surgery

Imaging Biomarkers of Delayed Sequelae in Trauma Brain Injury

Dosage Study for Vigamox Eye Drops Prior to Intravitreal Injections

TransForm™ Occlusion Balloon Catheter Registry

LOIS: Long-Term Follow-Up in INSITE/SIFI

Safety, Efficacy, Tolerability and Pharmacokinetics of LF111 (Drospirenone 4.0 mg) During 13 Cycles

Reevaluation Of Systemic Early Neuromuscular Blockade

Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy

Early Treatment of Amyotrophic Lateral Sclerosis (ALS) With Nutrition and Non-Invasive Positive Pressure Ventilation

Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer

Expanded Treatment Protocol (ETP) of Ruxolitinib in Patients With Polycythemia Vera Who Were Hydroxyurea Resistant or Intolerant and for Whom no Treatment Alternatives Was Available.

Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors

An Open-Label Extension Study Assessing the Long-Term Efficacy and Safety of ALX-0061 in Subjects With Rheumatoid Arthritis

Other Conditions in Chicago